drugset / Trial / NCT01242566
Temozolomide in Elderly Patients With KPS < 70
Phase 2
Completed
70 enrolled
Assistance Publique - Hôpitaux de Paris
Association de Neuro-Oncologues d'Expression Francaise · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The management of glioblastoma in elderly patients with poor performance status (KPS\<70) is unsettled. This single arm phase 2 trial trial was designed to evaluate the efficacy and safety of temozolomide alone in this population
Timeline
- Start
- 2007-07
- Primary completion
- 2010-05
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 150 mg/m2 | Oral |
| Subject | Temozolomide | Small molecule | 200 mg/m2 | Oral |